HOPEFIELD VENTURES TWO INC (HVII-P.CA) Stock Fundamental Analysis

TSX-V:HVII-P • CA43954M1077

0.46 CAD
-0.03 (-6.12%)
Last: Mar 12, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, HVII-P scores 2 out of 10 in our fundamental rating. HVII-P was compared to 0 industry peers in the Unkown industry. While HVII-P seems to be doing ok healthwise, there are quite some concerns on its profitability. HVII-P does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • HVII-P had negative earnings in the past year.
  • In the past year HVII-P has reported a negative cash flow from operations.
HVII-P.CA Yearly Net Income VS EBIT VS OCF VS FCFHVII-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -50K -100K

1.2 Ratios

Industry RankSector Rank
ROA -47.18%
ROE -52.2%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HVII-P.CA Yearly ROA, ROE, ROICHVII-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -5 -10

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HVII-P so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HVII-P.CA Yearly Profit, Operating, Gross MarginsHVII-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • HVII-P has more shares outstanding than it did 1 year ago.
  • HVII-P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HVII-P.CA Yearly Shares OutstandingHVII-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
HVII-P.CA Yearly Total Debt VS Total AssetsHVII-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200K 400K 600K 800K 1M

2.2 Solvency

  • An Altman-Z score of 34.43 indicates that HVII-P is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for HVII-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 34.43
ROIC/WACCN/A
WACCN/A
HVII-P.CA Yearly LT Debt VS Equity VS FCFHVII-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 200K 400K 600K 800K 1M

2.3 Liquidity

  • A Current Ratio of 10.41 indicates that HVII-P has no problem at all paying its short term obligations.
  • HVII-P has a Quick Ratio of 10.41. This indicates that HVII-P is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 10.41
Quick Ratio 10.41
HVII-P.CA Yearly Current Assets VS Current LiabilitesHVII-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for HVII-P have decreased strongly by -93.18% in the last year.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HVII-P. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HVII-P.CA Price Earnings VS Forward Price EarningsHVII-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HVII-P.CA Per share dataHVII-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HVII-P!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HOPEFIELD VENTURES TWO INC

TSX-V:HVII-P (3/12/2025, 7:00:00 PM)

0.46

-0.03 (-6.12%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners21.66%
Ins Owner ChangeN/A
Market Cap4.42M
Revenue(TTM)N/A
Net Income(TTM)-363.60K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.34
P/tB 6.34
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.18%
ROE -52.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.41
Quick Ratio 10.41
Altman-Z 34.43
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.53%
OCF growth 3YN/A
OCF growth 5YN/A

HOPEFIELD VENTURES TWO INC / HVII-P.CA FAQ

What is the fundamental rating for HVII-P stock?

ChartMill assigns a fundamental rating of 2 / 10 to HVII-P.CA.


What is the valuation status for HVII-P stock?

ChartMill assigns a valuation rating of 0 / 10 to HOPEFIELD VENTURES TWO INC (HVII-P.CA). This can be considered as Overvalued.


Can you provide the profitability details for HOPEFIELD VENTURES TWO INC?

HOPEFIELD VENTURES TWO INC (HVII-P.CA) has a profitability rating of 0 / 10.


What is the financial health of HOPEFIELD VENTURES TWO INC (HVII-P.CA) stock?

The financial health rating of HOPEFIELD VENTURES TWO INC (HVII-P.CA) is 6 / 10.